DENTSPLY International Inc. (NASDAQ:XRAY) in the third quarter as profit dropped from a year earlier. Net income for DENTSPLY International Inc. fell to $60.6 million (42 cents per share) vs. $63.7 million (44 cents per share) a year earlier. This is a decline of 4.8% from the year earlier quarter. Revenue rose 14.4% to $619.8 million from the year earlier quarter. XRAY reported adjusted net income of 46 cents per share. By that measure, the company beat the mean estimate of 43 cents per share. It beat the average revenue estimate of $600.4 million.
Bret Wise, Chairman and Chief Executive Officer, stated, “We are pleased to report another quarter of strong performance despite the orthodontic supply disruption in Japan.We are also excited to have closed the Astra Tech transaction during the quarter allowing us to begin the integration process earlier than we originally anticipated. We are pleased with the early assessment coming out of our integration efforts.”
Competitors to Watch: Young Innovations, Inc. (NASDAQ:YDNT), Align Technology, Inc. (NASDAQ:ALGN), Sirona Dental Systems, Inc. (NASDAQ:SIRO), Biolase Technology, Inc. (NASDAQ:BLTI), Pro-Dex, Inc. (NASDAQ:PDEX), Danaher Corporation (NYSE:DHR), Integra LifeSciences Hldgs. Corp. (NASDAQ:IART), 3M Company (NYSE:MMM), Cantel Medical Corp. (NYSE:CMN), and Zimmer Holdings, Inc. (NYSE:ZMH).
Cardinal Health Inc. (NYSE:CAH) reported its results for the first quarter. Net income for the drug wholesaler fell to $236.8 million (68 cents per share) vs. $294.8 million (84 cents per share) a year earlier. This is a decline of 19.7% from the year earlier quarter. Revenue rose 9.6% to $26.79 billion from the year earlier quarter. CAH reported adjusted net income of 73 cents per share. By that measure, the company beat the mean estimate of 72 cents per share. It beat the average revenue estimate of $26.18 billion.
“Our fiscal 2012 has started with a solid first quarter, driven by strong revenue gains from both of our segments, continued progress on our margin initiatives and contributions from our recent acquisitions,” said George Barrett, chairman and chief executive officer of Cardinal Health. “While we’re pleased with the performance of our business in this first quarter, we’re even more excited about the growth in strategic priority areas including specialty, positron emission tomography, generics, ambulatory, preferred medical products and China.Our progress in these areas provides increasing confidence that we’re positioning well for future growth.”
Competitors to Watch: AmerisourceBergen Corp. (NYSE:ABC), McKesson Corporation (NYSE:MCK), Integra LifeSciences Hldgs. Corp. (NASDAQ:IART), Thermo Fisher Scientific Inc. (NYSE:TMO), Teleflex Incorporated (NYSE:TFX), Covidien plc (NYSE:COV), General Electric Company (NYSE:GE), CVS Caremark Corporation (NYSE:CVS), Walgreen Company (NYSE:WAG), and Owens & Minor, Inc. (NYSE:OMI).
PSS World Medical Inc. (NASDAQ:PSSI) reported its results for the second quarter. Net income for PSS World Medical Inc. rose to $20 million (37 cents per share) vs. $19.6 million (35 cents per share) in the same quarter a year earlier. This marks a rise of 2.3% from the year earlier quarter. Revenue rose 5.2% to $521.8 million from the year earlier quarter. PSSI fell in line with the mean analyst estimate of 37 cents per share. Analysts were expecting revenue of $530 million.
David M. Bronson, Executive Vice President and Chief Financial Officer, commented, “The Company continued to execute well on our core strategies in the second quarter of fiscal 2012, offsetting very sluggish healthcare system utilization with share gains, operating improvements, and accretive deployment of capital.Second quarter operating margin, earnings per share, and return on committed capital were at or near historic highs, despite revenue growth challenges brought on by ongoing economic headwinds.
Competitors to Watch: Henry Schein, Inc. (NASDAQ:HSIC), Chindex Intl., Inc. (NASDAQ:CHDX), Patterson Companies, Inc. (NASDAQ:PDCO), Owens & Minor, Inc. (NYSE:OMI), Lincare Holdings Inc. (NASDAQ:LNCR), Cardinal Health, Inc. (NYSE:CAH) and AmerisourceBergen Corp. (NYSE:ABC).